Search

Search Results

• 

  Psoriatic arthritis: treatment strategies using biologic agents

  S. D'Angelo, C. Palazzi, I. Olivieri

  05-06-2012 Pages 113-121

  DOI https://doi.org/10.4081/reumatismo.2012.113

  • 1,630 abstract views
  • 1,308 PDF
• 

  Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?

  J. Mencarini, M. Spinicci, F. Bartalesi

  16-12-2016 Pages 144-147

  DOI https://doi.org/10.4081/reumatismo.2016.897

  • 2,678 abstract views
  • 1,299 PDF
• 

  Psoriatic arthritis. When the heterogeneity requires normality

  L. Punzi, R. Ramonda

  05-06-2012 Pages 59-65

  DOI https://doi.org/10.4081/reumatismo.2012.59

  • 1,143 abstract views
  • 821 PDF

• BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS

  D.D. Gladman

  Pages 85-87

  DOI https://doi.org/10.4081/reumatismo.2007.1s.85

  • 843 abstract views
  • 735 PDF

• Effects of TNF antagonists on immune and neuroendocrine system

  G. Valesini, M. Cutolo

  Pages 3-7

  DOI https://doi.org/10.4081/reumatismo.2005.4s.3

  • 1,667 abstract views
  • 928 PDF

• MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

  P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco

  Pages 132-139

  DOI https://doi.org/10.4081/reumatismo.2009.132

  • 2,265 abstract views
  • 1,291 PDF
• 

  Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis

  I. Olivieri, Salvatore D'Angelo, C. Palazzi, P. Leccese, A. Nigro, A. Padula

  28-03-2013 Pages 1-3

  DOI https://doi.org/10.4081/reumatismo.2013.1

  • 2,497 abstract views
  • 899 PDF

• IMMUNOPATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS AND PHARMACOLOGICAL PERSPECTIVES

  S. Loffredo, F. Ayala, G.C. Marone, A. Genovese, G. Marone

  Pages 28-39

  DOI https://doi.org/10.4081/reumatismo.2007.1s.28

  • 1,250 abstract views
  • 1,135 PDF

• PO:35:223 | Biologic therapy for sustained remission in eosinophilic myocarditis: real-world evidence from a tertiary center experience

  Federica Davanzo¹, Caterina Menghi², Andrea Silvio Giordani², Anna Baritussio², Federico Scognamiglio², Cristina Vicenzetto², Luca Iorio¹, Renzo Marcolongo², Cristina Basso³, Andrea Doria¹, Roberto Padoan¹, Alida Linda Patr Caforio² | ¹Rheumatology Unit, Department of Medicine, University of Padua Padova, Italy; ²Cardiology Unit, Department of Cardiac, Vascular, Thoracic Sciences and Public Health, University of Padua Padova, Italy; ³Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua Padova, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2383

  • 170 abstract views
• 

  COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

  Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

  19-11-2020 Pages 173-177

  DOI https://doi.org/10.4081/reumatismo.2020.1289

  • 2,221 abstract views
  • 1,256 PDF

• PO:04:048 | Assessment of chronic and residual pain in axial spondyloarthritis in a single-center cohort of patients treated with anti-tnf agents

  Valentina Fornero^1|2, Niccolò Melis¹, Emanuela Salustro¹, Mattia Congia¹, Elisabetta Chessa¹, Alberto Floris¹, Matteo Piga¹, Alberto Cauli¹ | ¹Rheumatology unit, AOU e Università di Cagliari; ²Asl Biella, Ospedale degli Infermi, Ponderano (BI), Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2128

  • 301 abstract views

• PO:36:252 | Long-Term Outcomes of Patients with Takayasu Arteritis in the Era of Biological Agents: a Multicenter International Study

  Alessandro Tomelleri¹, Durga Prasanna Misra², Fatma Alibaz-Oner³, Chiara Marvisi⁴, Chiara Calabrese¹, Upendra Rathore², Aysegul Avcu³, Adele Del Giudice⁴, Elisabetta Olivi⁴, Caterina Ricordi⁴, Corrado Campochiaro¹, Elena Baldissera¹, Marco Matucci-Cerinic¹, Haner Direskeneli³, Carlo Salvarani⁴, Lorenzo Dagna¹ | ¹IRCCS Ospedale San Raffaele, Unità di Immunologia, Reumatologia, Allergologia e Malattie Rare Milano, Italy; ²Sanjay Gandhi Postgraduate Institute of Medical Sciences SGPGIMS, Clinical Immunology and Rheumatology Lucknow Country, India; ³Marmara University, School of Medicine, Department of Internal Medicine, Division of Rheumatology Istanbul, Turkey; ⁴Azienda USL-IRCCS di Reggio Emilia, Unità di Reumatologia Reggio Emilia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2389

  • 167 abstract views

• Side effects of anti-TNFa therapy in juvenile idiopathic arthritis

  Irene Pontikaki, Valeria Gerloni, Maurizio Gattinara, Alfredomaria Lurati, Alessandra Salmaso, Gabriele De Marco, Barbara Teruzzi, Elisabetta Valcamonica, Flavio Fantini

  Pages 31-38

  DOI https://doi.org/10.4081/reumatismo.2006.31

  • 2,020 abstract views
  • 2,693 PDF

• Approved indications and other possible utilizations of anti-TNFa biologic drugs

  W. Grassi, C. Montecucco

  Pages 30-33

  DOI https://doi.org/10.4081/reumatismo.2005.4s.30

  • 1,456 abstract views
  • 974 PDF

• PO:08:116 | Rheumatoid nodulosis: incidence, clinical/instrumental description, and phenotypic correlations in patients with rheumatoid arthritis treated with b-DMARDs. A real-life analysis from a monocentric cohort

  Stefano Ruggiero¹, Elisa Montebelli³, Simone Bernardi², Marcello Natali⁴, Francesca Martelli¹, Alessandra Caula¹, Federica Landolfini¹, Gabriella Cucinotta¹, Sofia Giulianelli¹, Francesco Girelli² | ¹UOC Medicina Interna, Ospedale Morgagni-Pierantoni; Dipartimento di scienze Mediche e Chirurgiche Università di Bologna; ²UOS Reumatologia, Ospedale Morgagni-Pierantoni, Forlì; ³Università degli Studi di Bologna; ⁴UOC Radiologia, Ospedale Morgagni-Pierantoni, Forlì, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2141

  • 307 abstract views
• 

  Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study

  F.M. Perrotta, A. Delle Sedie, S. Scriffignano, P. Volpe, E. Cordisco, N. Milano, M. Gabini, E. Lubrano

  10-04-2020 Pages 52-59

  DOI https://doi.org/10.4081/reumatismo.2020.1266

  • 2,649 abstract views
  • 1,478 PDF
• 

  Coexisting rheumatoid arthritis and sickle cell disease: case series and literature review

  Abdallah Alqethami, Sabri Alsaeedi, Samera Felemban, Abdulelah Qadi

  07-01-2025

  DOI https://doi.org/10.4081/reumatismo.2025.1682

  • 2,979 abstract views
  • 906 PDF

• Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis

  L. Quartuccio, S. Salvin, M. Saracco, S. Lombardi, M. Fabris, E. Mansutti, M. Maset, S. Pellerito, S. De Vita

  Pages 182-186

  DOI https://doi.org/10.4081/reumatismo.2009.182

  • 1,205 abstract views
  • 883 PDF

• PO:10:155 | Etanercept-induced lupus in a patient with rheumatoid arthritis: diagnostic challenges and multidisciplinary therapeutic approach

  Camilla Riboldi^1|2, Claudia Iannone^1|2, Maria Gerosa^1|2, Roberto Felice Caporali^1|2 | ¹ASST G. Pini-CTO, U.O.C. di Clinica Reumatologica, Milano; ²Dipartimento di Scienze Cliniche e di Comunità, Università degli Studi di Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2149

  • 382 abstract views

• PO:17:259 | Anifrolumab: a new management of SLE

  Giorgia Montozzi¹, Chiara Cocco¹, Ramona Santangeli¹, Lucia Gamba¹, Paola Fioretti¹, Letizia Curina¹, Chiara Guidoni¹, Edoardo Cipolletta³, Gianluca Moroncini² | ¹Scuola di Specializzazione in Medicina Interna, Università Politecnica delle Marche Ancona, Italy; ²Department of Clinical and Molecular Sciences, Università Politecnica delle Marche Ancona, Italy; ³Rheumatology Unit, Department of Clinical and Molecular Sciences , Università Politecnica delle Marche Ancona, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2336

  • 234 abstract views

• PO:01:004 | Real-world retention of IL-17 inhibitors in psoriatic arthritis: impact of prior IL-17 exposure across multiple treatment lines in the “BIRRA” multicentre cohort

  Valentino Paci¹, Alarico Ariani², Eleonora Celletti³, Alberto Lo Gullo⁴, Camilla Mazzanti⁵, Valeria Nucera⁶, Natalia Mansueto⁷, Rosalba Caccavale⁸, Patrizia Del Medico⁹, Antonella Farina¹⁰, Palma Scolieri¹¹, Cecilia Giampietro¹², Olga Addimanda¹³, Riccardo Bixio¹⁴, Maddalena Larosa¹⁵, Viviana Ravagnani¹⁶, Federica Lumetti¹⁷, Aldo Biagio Molica Colella¹⁷, Elena Bravi¹⁷, Rosetta Vitetta¹⁷, Bernd Raffeiner¹⁷, Gilda Sandri¹⁸, Rosario Foti¹⁹, Simone Parisi²⁰, Michele Maria Luchetti Gentiloni¹, Gianluca Moroncini¹. | ¹Clinical Medicine, Department of Clinical and Molecular Sciences, Marche Polytechnic University, AOU delle Marche, Ancona, Italy; ²Internal Medicine and Rheumatology Unit, University Hospital of Parma, Parma, Italy; ³Rheumatology Unit, Clinica Medica Institute, Ospedale SS. Annunziata di Chieti, G.d'Annunzio University of Chieti, Chieti, Italy; ⁴Rheumatology Unit, ARNAS Garibaldi di Catania, Catania, Italy; ⁵Center for the Diagnosis and Therapy of Autoimmune Rheumagological Diseases, Ospedale Santa Rosa, ASL Viterbo Viterbo Italy; ⁶Rheumatology Outpatient Unit, ASL Novara, Novara, Italy; ⁷Ambulatori di Reumatologia ASL1 Liguria, Imperia Hospitall Imperia Italy; ⁸Department of Clinical, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Polo Pontino, Roma, Italy; ⁹Rheumatology outpatient clinic - Internal Medicine Unit, Civitanova Marche Hospital, Civitanova Marche, Italy; ¹⁰Internal Medicine Unit, Rheumatology outpatient clinic, Ospedale A. Murri di Fermo, Fermo, Italy; ¹¹Department of Medical Specialties, Nuovo Regina Margherita Hospital, Rome, Roma, Italy; ¹²Rheumatology Outpatient Clinic, Azienda ULSS 6 Euganea, Padova, Padova, Italy; ¹³Rheumatology Unit, Azienda Unità Sanitaria Locale di Bologna -- Policlinico S.Orsola- AOU di Bologna, Bologna, Italy; ¹⁴Rheumatology Unit, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy; ¹⁵Division of Rheumatology - Medical Specialties Department, Ospedale La Colletta-Azienda Sanitaria Locale 3, Genova, Italy; ¹⁶Rheumatology Unit, Santa Chiara Hospital APSS Trento Italy; ¹⁷BIRRA - BIologic Retention Rate in chronic Arthritis - study group, Parma, Italy; ¹⁸Rheumatology Unit, University of Modena and Reggio Emilia, Modena, Italy; ¹⁹Rheumatology Unit, Policlinico San Marco Hospital, Catania, Italy; ²⁰Rheumatology Department, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2001

  • 393 abstract views

• PO:23:055 | Overlap of systemic sclerosis and Sjögren’s disease: insights from an Italian case-control study

  Stefano Stano¹, Fabio Cacciapaglia^1|2, Maria Morrone¹, Simone Perniola¹, Marco Capodiferro¹, Marco Fornaro¹, Laura Coladonato¹, Giuseppe Lopalco¹, Florenzo Iannone¹. | ¹Rheumatology Unit - Department of Precision and Regenerative Medicine, Jonian Area DiPReMeJ, University of Bari, Bari, Italy; ²Rheumatology Service, Internal Medicine Unit F. Miulli General Hospital, Department of Medicine and Surgery, LUM Casamassima Italy.

  Società Italiana di Reumatologia

  25-11-2025

  DOI https://doi.org/10.4081/reumatismo.2025.2057

  • 487 abstract views

• PO:31:169 | From Crisis to Chronicity: A Real-World Study of Renal Dysfunction in Systemic Sclerosis

  Stefano Stano¹, Fabio Cacciapaglia^1|2, Giorgia Campanale¹, Simone Perniola¹, Maria Morrone¹, Andrea Cito¹, Vincenzo Venerito¹, Maria Grazia Anelli¹, Giuseppe Lopalco¹, Florenzo Iannone¹ | ¹Rheumatology Unit - Department of Precision and Regenerative Medicine, Jonian Area DiPReMeJ, University of Bari Bari, Italy; ²Rheumatology Service, Internal Medicine Unit F. Miulli General Hospital, Department of Medicine and Surgery, LUM Casamassima, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2368

  • 101 abstract views

• PO:08:119 | Infusional Advantage: Rituximab’s Role in Enhancing Adherence in Multimorbid Rheumatoid Arthritis

  Marco Capodiferro¹, Daniele Domanico¹, Angelica Napoletano¹, Giulia Righetti², Patrizia Suppressa², Vincenzo Venerito¹, Giuseppe Lopalco¹, Florenzo Iannone¹, Fabio Cacciapaglia^1|2 | ¹Rheumatology Unit, Department of Precision and Regenerative Medicine and Jonian Area DiMePRe-J University of Bari, Italy; ²Department of Medicine and Surgery, Miulli General Hospital Acquaviva delle Fonti - LUM University Casamassima Bari Acquaviva delle Fonti, Bari, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2307

  • 142 abstract views

• PO:35:234 | Sustained Vasculitis Quiescence and CS Reduction with Mepolizumab 100 mg

  Francesca Mascia¹, Angelo Fassio², Marco Zurlo¹, Davide Chesini³, Francesco Pollastri², Giovanni Adami², Davide Gatti⁴, Maurizio Rossini⁴, Matteo Maule⁵, Gianentrico Senna¹, Marco Caminati¹ | ¹University of Verona - Allergology and Clinical Immunology Verona, Italy; ²Policlinico G. B. Rossi - Rheumatology Verona, Italy; ³University of Verona - Faculty of Medicine and Surgery Verona, Italy; ⁴University of Verona - Rheumatology Verona, Italy; ⁵Policlinico G. B. Rossi - Allergology and Clinical Immunology Verona, Italy

  Società Italiana di Reumatologia

  18-03-2026

  DOI https://doi.org/10.4081/reumatismo.2025.2387

  • 107 abstract views